KEEP EYE 👀 ON JOCIL
CMP:- 160 / 161
Stock once moves above 163 level today, we may see 167 / 170 / 175 / 181 / 188++ in intraday & 200 - 225++ in mid term.
High Conviction for short term.
Inverse Head & Shoulder Breakout done ✅
CMP:- 160 / 161
Stock once moves above 163 level today, we may see 167 / 170 / 175 / 181 / 188++ in intraday & 200 - 225++ in mid term.
High Conviction for short term.
Inverse Head & Shoulder Breakout done ✅
❤1
BIOCON says
US FDA Is Signalling There Is No Real Need For Phase 3 Trials, Doing Away With Phase 3 Trials Will Be A Relief For Patients
Change In Biosimilar Policies In The US Will Aid Incumbents
US FDA Is Signalling There Is No Real Need For Phase 3 Trials, Doing Away With Phase 3 Trials Will Be A Relief For Patients
Change In Biosimilar Policies In The US Will Aid Incumbents